Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dificid in Clostridium difficile-associated diarrhea
NCT00314951Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- May 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of fidaxomicin in Clostridium difficile infection (CDI), sponsored by Merck & Co.. Started May 2006; status: completed.
02
Drugs
fidaxomicin
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT00314951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314951.